West Pharmaceutical Services (WST) Shares Repurchased (2009 - 2026)

West Pharmaceutical Services' Shares Repurchased history runs 15 years deep, the most recent figure standing at $297.6 million for Q1 2026.

• In Q1 2026, Shares Repurchased rose 122.92% year-over-year to $297.6 million; the TTM figure through Mar 2026 stood at $298.1 million (down 30.25% YoY), while the FY2025 annual figure was $134.0 million, down 76.11% from the prior year.
• Shares Repurchased came in at $297.6 million for Q1 2026 at West Pharmaceutical Services, up from $500000.0 in the prior quarter.
• In the past five years, Shares Repurchased ranged from a high of $297.6 million in Q1 2026 to a low of -$100000.0 in Q4 2022.
• A 5-year average of $108.9 million and a median of $60.1 million in 2023 frame the typical range for Shares Repurchased.
• Across the five-year window, Shares Repurchased jumped 177100.0% in 2023 and slumped 99.73% in 2025, its largest moves.
• West Pharmaceutical Services' Shares Repurchased stood at -$100000.0 in 2022, then surged by 177100.0% to $177.0 million in 2023, then slumped by 69.27% to $54.4 million in 2024, then sank by 99.08% to $500000.0 in 2025, then soared by 59420.0% to $297.6 million in 2026.
• According to Business Quant data, Shares Repurchased over the past three periods registered $297.6 million, $500000.0, and $133.5 million for Q1 2026, Q2 2025, and Q1 2025 respectively.

Peer Comparison